HealthNet Homecare
Health Technology Patient Support.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Growth Equity VC | |
| Total Funding | 000k | ||
HealthNet Homecare, established in 2015, operates as a clinical homecare provider in the United Kingdom, structuring its services around partnerships with the National Health Service (NHS) and pharmaceutical companies. The company was founded by Kerry Hinton, who continues to lead the business as CEO. Since its inception as a startup, the company has grown to be one of the largest providers of these services in the UK, serving over 200,000 patients with conditions ranging from chronic and acute illnesses to rare and orphan diseases.
The firm’s business model is centered on delivering medications and associated clinical support directly to patients' homes, a service that alleviates pressure on hospital infrastructure and facilitates community-based care. HealthNet generates revenue by providing a suite of services including the dispensing, storage, and controlled delivery of specialist medicines, alongside patient management and support programs. This includes tailored solutions for more than 30 complex therapy areas, with options for both purchase and consignment stock models. A key milestone for the company was a significant investment from private equity firm CBPE in late 2024, which is intended to support the next phase of growth. Additionally, the company acquired Biodose Services in 2017 and later, in 2021, acquired the share capital previously owned by its parent company, Lexon UK Limited, with financial support from Barclays Corporate Banking.
HealthNet Homecare offers a comprehensive service portfolio designed to manage the clinical pathways for patients outside of traditional hospital settings. Core services include medication delivery to a patient's chosen location, training on medication use by registered nurses, and ongoing nurse administration for more complex treatments. The company operates dedicated pharmacy care teams to address patient concerns and provides support for individuals receiving IVF treatment through its fertility division, Stork Fertility. The entire service is regulated by multiple bodies, including the Care Quality Commission (CQC), which has rated the service 'Good', and the General Pharmaceutical Council, ensuring adherence to high standards of safety and care.
Keywords: clinical homecare, NHS partnership, pharmaceutical services, patient support programs, medication delivery, home nursing services, chronic disease management, rare disease support, specialty pharmacy, community healthcare, IVF services, Stork Fertility, patient-centered care, UK healthcare, remote patient care, medication management, clinical support, healthcare logistics, private equity backed, CBPE